Publications

Journal Article Epublish 1 citations
Open access — free full text available
Open access
Electronic publication date
August 2, 2026

View on Pubmed.gov 42539970 | View on doi.org 10.1016/j.ero.2... | View the free full text Full text

Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey.

Search for publications in this journal EULAR Rheumatol Open - 2(2):100156

EULAR Cardiovascular in inflammatory arthritis (CVIIA) Study Group members

Abstract

OBJECTIVES

Inflammatory rheumatic and musculoskeletal diseases (RMDs) are hallmarked by an increased risk of cardiovascular (CV) disease compared with the general population. Evidence suggests that CV risk remains under-recognised and underdiscussed in routine care, although data on patient experience is lacking. We aimed to assess awareness, perceptions, and experiences regarding CV risk and prevention in patients with RMDs.

METHODS

An anonymous, online survey was codesigned by rheumatologists, researchers, and patient research partners in English language and translated into 9 languages. This was distributed through patient organisations/forums and social media.

RESULTS

A total of 951 patients with RMDs from 43 countries (mainly females, aged 50-70 years, and with a diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus) completed the survey. Although 68% of respondents acknowledged an increased CV risk in RMDs, and traditional CV risk factors were recognised by up to 60% of the participants, knowledge of disease-specific contributors (eg, disease activity) to CV risk was limited. Only 35% of respondents had ever discussed CV risk with a healthcare provider, mainly rheumatologists or cardiologists, and the content primarily focused on lifestyle advice. Lack of awareness on the topic relevance (38%), perceived complexity of the topic (25%), limited time of clinical visits (35%), and lack of informative materials (33%) emerged as the main key barriers among those poorly/not informed.

CONCLUSIONS

This large, multinational survey demonstrates substantial gaps in CV risk awareness, knowledge, and patient-provider communication among patients with RMDs. These figures support the development of structured, patient-centred educational strategies and enhanced multidisciplinary communication schemes to improve CV prevention in RMDs.

References

Conrad N., Verbeke G., Molenberghs G., Goetschalckx L., Callender T., Cambridge G., et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733–743.

Mortensen M.B., Jensen J.M., Rønnow Sand N.P., Kragholm K., Blaha M.J., Grove E.L., et al. Association of autoimmune diseases with coronary atherosclerosis severity and ischemic events. J Am Coll Cardiol. 2024 Jun 25;83(25):2643–2654.

Porsch F., Binder CJ. Autoimmune diseases and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024 Nov;21(11):780–807.

Nygaard L., Polcwiartek C., Nelveg-Kristensen K.E., Carlson N., Kristensen S., Torp-Pedersen C., et al. Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study. Rheumatology (Oxford) 2024 May 2;63(5):1313–1321.

Conflict of interest statement

All authors declare they have no competing interests.

MeSH

Specialties

Copyright

© 2026 The Author(s).